Skip to main content
Clinical Trials/NCT03503682
NCT03503682
Unknown
N/A

SHort Course Accelerated RadiatiON Therapy (SHARON) in Complicated Bone Metastases Palliation: an Interventional, Randomised, Multicentric Study

IRCCS Azienda Ospedaliero-Universitaria di Bologna1 site in 1 country82 target enrollmentNovember 8, 2017

Overview

Phase
N/A
Intervention
Not specified
Conditions
Bone Metastases
Sponsor
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Enrollment
82
Locations
1
Primary Endpoint
Efficacy of palliation using the short course scheme compared with the standard scheme
Last Updated
8 years ago

Overview

Brief Summary

Aim of the study is to assess efficacy of a short course radiation treatment in patients with complicated bone metastases

Detailed Description

Standard treatment for complicated bone metastases (3000 cGy in 10 daily fractions of 300 cGy each) is compared with experimental treatment (4000 cGy in 4 fractions of 500 cGy twice a day) to demonstrate non-inferiority of this scheme.

Registry
clinicaltrials.gov
Start Date
November 8, 2017
End Date
November 8, 2023
Last Updated
8 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Alessio Giuseppe Morganti

Professor

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Eligibility Criteria

Inclusion Criteria

  • complicated bone metastases from any solid tumor
  • age \>18 years
  • ECOG performance status 0-3
  • symptomatic lesion (NRS \>1)
  • no changes in analgesic treatment at least in the week before radiotherapy

Exclusion Criteria

  • pregnancy
  • previously irradiation of the same region

Outcomes

Primary Outcomes

Efficacy of palliation using the short course scheme compared with the standard scheme

Time Frame: 3 months

Reduction of pain after radiotherapy, assessed with VAS (visual analogue scale)

Secondary Outcomes

  • Acute toxicity in the two treatment groups(3 months)
  • Late toxicity in the two treatment groups(12 months)
  • Quality of Life (QoL) assessment in the two groups(12 months)

Study Sites (1)

Loading locations...

Similar Trials